Presentations will be made by scientists on the existing medical and scientific literature on the therapeutic utility of marijuana. A consultant review group with expertise in such fields as clinical pharmacology, oncology, ophthalmology, infectious diseases, and clinical trials will consider the presentations and other written materials in their deliberations on the four questions. The review group's conclusions will assist the NIH Director in considering actions NIH could take to fund research on the therapeutic potential of marijuana for patients with specific illnesses.
** Note to medical news media: There will be a press availability on February 20, from 1:00 p.m. - 1:30 p.m. in the Natcher Conference Center.
For additional information, call NIH Office of Communications, 301-496-5787.